Jazz Pharmaceuticals's market cap is currently $8.18B. The company's EPS TTM is $6.942; its P/E ratio is 19.44; Jazz Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $5.81. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.83B	$ 3.66B	$ 3.09B	$ 2.36B	$ 2.16B
Gross Profit	$ 3.40B	$ 3.12B	$ 2.65B	$ 2.21B	$ 2.03B
Operating Income	$ 578.58M	$ 512.27M	$ 170.28M	$ 765.46M	$ 532.37M
EBITDA	$ 1.23B	$ 553.78M	$ 1.03B	$ 649.65M	$ 1.01B
Net Income	$ 414.83M	$ -214.14M	$ -328.95M	$ 238.62M	$ 523.37M
Balance Sheet
Cash & Short-Term Investments	$ 1.63B	$ 881.48M	$ 591.45M	$ 2.13B	$ 1.08B
Total Assets	$ 11.39B	$ 10.84B	$ 12.30B	$ 6.54B	$ 5.54B
Total Debt	$ 5.79B	$ 5.80B	$ 6.14B	$ 2.23B	$ 1.76B
Net Debt	$ 4.29B	$ 4.91B	$ 5.55B	$ 1.18B	$ 1.12B
Total Liabilities	$ 7.66B	$ 7.75B	$ 8.33B	$ 2.88B	$ 2.43B
Stockholders' Equity	$ 3.74B	$ 3.09B	$ 3.97B	$ 3.66B	$ 3.11B
Cash Flow
Free Cash Flow	$ 1.07B	$ 773.78M	$ 732.98M	$ 520.39M	$ 594.07M
Operating Cash Flow	$ 1.09B	$ 1.27B	$ 778.51M	$ 899.65M	$ 776.40M
Investing Cash Flow	$ -163.06M	$ -446.23M	$ -5.21B	$ -1.01B	$ -155.30M
Financing Cash Flow	$ -305.25M	$ -529.49M	$ 3.97B	$ 528.07M	$ -293.75M

Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Income Statement >

Jazz Pharmaceuticals Debt to Assets

Balance Sheet >

Jazz Pharmaceuticals Cash Flow

Cash Flow >

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing